Scalable and reversible axonal neuromodulation of the sympathetic chain for cardiac control
Joseph Hadaya, Una Buckley, Nil Z. Gurel, Christopher A. Chan, Mohammed Amer Swid, Niloy Bhadra, Tina Vrabec, Jonathan D. Hoang, Corey Smith, Kalyanam Shivkumar, Jeffrey L. Ardell
Abstract
Autonomic imbalance and excess sympathetic activity have been implicated in the pathogenesis of cardiovascular disease and are targets for existing medical therapy. Neuromodulation may allow for control of sympathetic projections to the heart in an on-demand and reversible manner. This study provides proof-of-concept evidence that axonal modulation therapy (AMT) blocks sympathoexcitation by defining scalability, sustainability, and memory properties of AMT. Moreover, AMT directly reduces release of myocardial norepinephrine, a mediator of arrhythmias and heart failure.